Sessions and Speakers

9:30-18:00 June 5th, 2018. The Royal Academy of Engineering

08:30 - 09:30

Registration and Coffee

09:30 - 10:30

Welcome: The UK Landscape for Synthetic Biology

Prof Richard Kitney and Prof Paul Freemont, Co-Directors, SynbiCITE

Introduction: The UK Bioeconomy

Rt Hon. Lord David Willetts, MP

10:30 - 11:15

Sustaining the future of engineering biology in the UK

Session 1 - Panel Discussion:

Policy, practical requirements, and commercialisation strategies that are needed to deliver the vision of building a successful synthetic biology industry in the UK

Chair: Rt Hon. Lord David Willetts, MP

11:15 - 11:30

Coffee Break

11:30 - 12:30

Showcasing the future of engineering biology in the UK: today’s innovation shaping tomorrow
Session 2 - Company Showcase:

UK Companies applying engineering biology to solve important issues confronting society – showcasing their technology, journey and future

Chair: Prof Richard Kitney, Co-Director, SynbiCITE
Presenting Companies:
Synpromics - Michael Roberts, Founder and CSO
Customem - Ben Reeve, CTO
Prokarium - Rocky Cranenburgh, CSO
Prozomix - Simon Charnock, Managing Director / Technical Director

12:30 - 13:15

Innovation and scale up: global company showcase
Session 3 - Company Showcase:

The fundamental technologies improving health care, optimising automation, and reducing waste

Chair: Prof Paul Freemont, Co-Director, SynbiCITE
Presenting Companies:
GSK - David Tew, Technical Project Lead, Biological Technologies
CyBio - Chris Hirst, Application Development Scientist
Singer Instruments - Harry Singer, Singer Instruments

More companies to be announced soon



13:45 – 14:30

Strategic Policies – Catalysts for better outcomes
Session 4 - Panel Discussion:

Why supporting "game changing" science and engineering is critical to UK economic success

Chair: Lionel Clarke, Co-Chair, Synthetic Biology Leadership Council

14:30 – 15:30

Engineering biology game changers – AI, Gene Editing, Lab Automation and DNA Storage
Session 5 - Company Showcase:

Transformative applications and collaborations driving the UK’s engineering biology industry forward

Chair: Prof Richard Kitney, SynbiCITE
Presenting companies:
LabGenius - James Field, CEO and Founder
Microsoft - Andrew Phillips, Head of Bio Computation group
Synthace - Tim Fell, CEO
Desktop Genetics - Victor Dillard, COO and Founder


Coffee Break

15:45 – 16:30

Investing in Transformative Technologies
Session 6 - Panel Discussion:

Global investment, matching entrepreneurs and investment, and keeping talent in the UK

Chair: Malcolm Glaister, CEO, Eight Great Technologies

16:30 – 17:00

Maintaining and advancing the foundation of synthetic biology research and innovation in the UK
Session 7 - Panel Discussion:

The skills, training, and resources needed to sustain engineering biology in the UK

Chairs: Prof Richard Kitney and Prof Paul Freemont, Co-Directors, SynbiCITE


Closing Address


Networking Reception

Sponsored by